Dashboard
Manage Tickers

FENC FENNEC PHARMACEUTICALS INC.


$ 7.85 $ 0.04 (0.51 %)    

Friday, 21-Nov-2025 15:56:22 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 589.60 $ 4.40 (0.75 %)
DIA $ 462.45 $ 5.05 (1.1 %)
SPY $ 658.47 $ 6.50 (1 %)
TLT $ 89.50 $ 0.27 (0.3 %)
GLD $ 373.70 $ -0.58 (-0.15 %)
$ na
$ 7.80
$ 7.79 x 108
$ 7.84 x 53
$ 7.73 - $ 8.10
$ 4.68 - $ 9.92
264,005
na
221.56M
$ 0.72
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

reported-earlier-fennec-pharmaceuticals-prices-offering-of-4666667-common-shares-at-750-per-share-for-35m-in-gross-proceeds
Reported Earlier, Fennec Pharmaceuticals P...
11/14/2025 07:35:50

Fennec intends to use the net proceeds of the offering to repurchase and redeem certain indebtedness and the remaining net proc...

fennec-pharmaceuticals-q3-eps-002-inline-sales-12462m-beat-11257m-estimate
Fennec Pharmaceuticals Q3 EPS $(0.02), Inl...
11/13/2025 22:32:18

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. T...

Core News & Articles
Fennec Pharmaceuticals Plans To Launch Com...
11/13/2025 21:09:54

Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) ("Fennec" or the "Company"), a specialty pharmaceutical com...

hc-wainwright--co-reiterates-buy-on-fennec-pharmaceuticals-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Fenn...
08/21/2025 14:36:20

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and maintains ...

craig-hallum-maintains-buy-on-fennec-pharmaceuticals-raises-price-target-to-14
Craig-Hallum Maintains Buy on Fennec Pharm...
08/15/2025 17:38:33

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price targ...

fennec-pharmaceuticals-q2-eps-011-misses-004-estimate-sales-965m-beat-952m-estimate
Fennec Pharmaceuticals Q2 EPS $(0.11) Miss...
08/14/2025 10:09:29

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate...

Core News & Articles
Earnings Scheduled For August 14, 2025
08/14/2025 08:32:32

fennec-pharmaceuticals-earnings-preview
Fennec Pharmaceuticals Earnings Preview
08/13/2025 18:02:09

hc-wainwright--co-reiterates-buy-on-fennec-pharmaceuticals-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Fenn...
05/20/2025 10:54:44

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and maintains ...

craig-hallum-maintains-buy-on-fennec-pharmaceuticals-raises-price-target-to-13
Craig-Hallum Maintains Buy on Fennec Pharm...
05/14/2025 17:48:12

Craig-Hallum analyst Chase Knickerbocker maintains Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price targ...

fennec-pharmaceuticals-q1-eps-004-beats-009-estimate-sales-875m-beat-818m-estimate
Fennec Pharmaceuticals Q1 EPS $(0.04) Beat...
05/13/2025 10:05:45

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

hc-wainwright--co-reiterates-buy-on-fennec-pharmaceuticals-maintains-13-price-target
HC Wainwright & Co. Reiterates Buy on Fenn...
03/11/2025 10:52:44

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and maintains ...

nasdaq-sp-500-hit-6-month-lows-as-recession-fears-grow-whats-driving-markets-monday
Nasdaq, S&P 500 Hit 6-Month Lows As Recess...
03/10/2025 16:59:43

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq ...

fennec-pharmaceuticals-q4-2024-gaap-eps-006-up-from-010-yoy-sales-792m-down-from-973m-yoy
Fennec Pharmaceuticals Q4 2024 GAAP EPS $(...
03/10/2025 10:06:22

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.06) per share. This is a 40 percent increase over losses ...

earnings-scheduled-for-march-10-2025
Earnings Scheduled For March 10, 2025
03/10/2025 08:32:14

why-bp-shares-are-trading-higher-by-6-here-are-20-stocks-moving-premarket
Why BP Shares Are Trading Higher By 6%; He...
02/10/2025 11:08:13

fennec-pharmaceuticals-announces-commercial-launch-of-pedmarqsi-in-germany-which-is-the-first-and-only-approved-therapy-in-the-eu-and-uk-for-prevention-of-ototoxicity-or-hearing-loss-induced-by-cisplatin-chemotherapy
Fennec Pharmaceuticals Announces Commercia...
02/07/2025 12:10:14

Core News & Articles
Fennec's PEDMARQSI Gains National Institut...
12/20/2024 11:19:34

Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a specialty pharmaceutical company, today announced that Norgine Pharmaceut...

fennec-pharmaceuticals-announced-the-early-repayment-of-13m-of-its-approximately-32m-outstanding-convertible-debt-facility-with-petrichor-healthcare-capital-management
Fennec Pharmaceuticals Announced The Early...
12/19/2024 11:26:18

Pro forma for repayment, the convertible debt facility with Petrichor will be approximately $19 million and maintain a maturity...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION